Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin

Smita S. Joshi, Susan L. Boone, Murad Alam, Simon S Yoo, Lucile White, Alfred W Rademaker, Irene Helenowski, Dennis P West, Roopal Vashi Kundu

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background There are no randomized split-face model studies investigating treatments for postinflammatory hyperpigmentation (PIH) in dark skin. Objective To assess the efficacy, safety, and effect on quality of life of salicylic acid peels for PIH in dark skin. METHODS Ten subjects with Fitzpatrick skin phototypes IV to VI were randomized to receive two 20% salicylic acid peels followed by three 30% salicylic acid peels to half of the face. The contralateral half remained untreated. Response was evaluated by photography reviewed by three blinded dermatologists. The Visual Analog Scale, Dermatology Life Quality Index (DLQI), and treatment quality questionnaire were administered. Results Improvement of PIH on the treatment side according to each rater (p=.81, p=.81, p=.42) and according to the raters combined (p=.11) approached but did not reach statistical significance. Subjects' Visual Analog Scale scores indicated significantly greater improvement of PIH on the treatment side than in the control (p=.004). Quality of life measured according to the DLQI improved after treatment but not statistically significantly so (p=.13). Treatment had no significant adverse effects. ConclusionS Salicylic acid peels are safe in this population. Although patients rated them as clinically effective, blinded raters found a brief series of peels to have less efficacy. Measured quality of life improved nominally. The authors have indicated no significant interest with commercial supporters.

Original languageEnglish (US)
Pages (from-to)638-644
Number of pages7
JournalDermatologic Surgery
Volume35
Issue number4
DOIs
StatePublished - Apr 1 2009

Fingerprint

Hyperpigmentation
Salicylic Acid
Quality of Life
Safety
Skin
Dermatology
Visual Analog Scale
Therapeutics
Photography
Population

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Cite this

@article{a9c25098c0b04481ba0e32b5beb0602b,
title = "Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin",
abstract = "Background There are no randomized split-face model studies investigating treatments for postinflammatory hyperpigmentation (PIH) in dark skin. Objective To assess the efficacy, safety, and effect on quality of life of salicylic acid peels for PIH in dark skin. METHODS Ten subjects with Fitzpatrick skin phototypes IV to VI were randomized to receive two 20{\%} salicylic acid peels followed by three 30{\%} salicylic acid peels to half of the face. The contralateral half remained untreated. Response was evaluated by photography reviewed by three blinded dermatologists. The Visual Analog Scale, Dermatology Life Quality Index (DLQI), and treatment quality questionnaire were administered. Results Improvement of PIH on the treatment side according to each rater (p=.81, p=.81, p=.42) and according to the raters combined (p=.11) approached but did not reach statistical significance. Subjects' Visual Analog Scale scores indicated significantly greater improvement of PIH on the treatment side than in the control (p=.004). Quality of life measured according to the DLQI improved after treatment but not statistically significantly so (p=.13). Treatment had no significant adverse effects. ConclusionS Salicylic acid peels are safe in this population. Although patients rated them as clinically effective, blinded raters found a brief series of peels to have less efficacy. Measured quality of life improved nominally. The authors have indicated no significant interest with commercial supporters.",
author = "Joshi, {Smita S.} and Boone, {Susan L.} and Murad Alam and Yoo, {Simon S} and Lucile White and Rademaker, {Alfred W} and Irene Helenowski and West, {Dennis P} and Kundu, {Roopal Vashi}",
year = "2009",
month = "4",
day = "1",
doi = "10.1111/j.1524-4725.2009.01103.x",
language = "English (US)",
volume = "35",
pages = "638--644",
journal = "Dermatologic Surgery",
issn = "1076-0512",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin

AU - Joshi, Smita S.

AU - Boone, Susan L.

AU - Alam, Murad

AU - Yoo, Simon S

AU - White, Lucile

AU - Rademaker, Alfred W

AU - Helenowski, Irene

AU - West, Dennis P

AU - Kundu, Roopal Vashi

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Background There are no randomized split-face model studies investigating treatments for postinflammatory hyperpigmentation (PIH) in dark skin. Objective To assess the efficacy, safety, and effect on quality of life of salicylic acid peels for PIH in dark skin. METHODS Ten subjects with Fitzpatrick skin phototypes IV to VI were randomized to receive two 20% salicylic acid peels followed by three 30% salicylic acid peels to half of the face. The contralateral half remained untreated. Response was evaluated by photography reviewed by three blinded dermatologists. The Visual Analog Scale, Dermatology Life Quality Index (DLQI), and treatment quality questionnaire were administered. Results Improvement of PIH on the treatment side according to each rater (p=.81, p=.81, p=.42) and according to the raters combined (p=.11) approached but did not reach statistical significance. Subjects' Visual Analog Scale scores indicated significantly greater improvement of PIH on the treatment side than in the control (p=.004). Quality of life measured according to the DLQI improved after treatment but not statistically significantly so (p=.13). Treatment had no significant adverse effects. ConclusionS Salicylic acid peels are safe in this population. Although patients rated them as clinically effective, blinded raters found a brief series of peels to have less efficacy. Measured quality of life improved nominally. The authors have indicated no significant interest with commercial supporters.

AB - Background There are no randomized split-face model studies investigating treatments for postinflammatory hyperpigmentation (PIH) in dark skin. Objective To assess the efficacy, safety, and effect on quality of life of salicylic acid peels for PIH in dark skin. METHODS Ten subjects with Fitzpatrick skin phototypes IV to VI were randomized to receive two 20% salicylic acid peels followed by three 30% salicylic acid peels to half of the face. The contralateral half remained untreated. Response was evaluated by photography reviewed by three blinded dermatologists. The Visual Analog Scale, Dermatology Life Quality Index (DLQI), and treatment quality questionnaire were administered. Results Improvement of PIH on the treatment side according to each rater (p=.81, p=.81, p=.42) and according to the raters combined (p=.11) approached but did not reach statistical significance. Subjects' Visual Analog Scale scores indicated significantly greater improvement of PIH on the treatment side than in the control (p=.004). Quality of life measured according to the DLQI improved after treatment but not statistically significantly so (p=.13). Treatment had no significant adverse effects. ConclusionS Salicylic acid peels are safe in this population. Although patients rated them as clinically effective, blinded raters found a brief series of peels to have less efficacy. Measured quality of life improved nominally. The authors have indicated no significant interest with commercial supporters.

UR - http://www.scopus.com/inward/record.url?scp=64349121963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64349121963&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4725.2009.01103.x

DO - 10.1111/j.1524-4725.2009.01103.x

M3 - Article

VL - 35

SP - 638

EP - 644

JO - Dermatologic Surgery

JF - Dermatologic Surgery

SN - 1076-0512

IS - 4

ER -